Effect of rosuvastatin on clinical prognosis in patients with acute myocardial infarction complicated with atrial fibril -lation
Dong Li,Qian Gong,Liang Zhao,Min Dai,Caidong Luo
DOI: https://doi.org/10.3969/j.issn.0253-9926.2018.09.003
2018-01-01
Abstract:Objective To explore the clinical outcomes of rosuvastatin in patients with acute myocardial in-farction complicated with atrial fibrillation.Methods One hundred and sixty-two patients with acute myocardial infarction complicated with atrial fibrillation were randomly divided into 3 groups and treated with different doses of rosuvastatin and conventional treatment,respectively.Comparing the statistical differences between the groups before and after the treatment of cardiac function,blood lipids,and inflammation.Results After treatment,there were statistically significant differences in LVEF,LVESD,LVEDD,FS,TG,TC,HDL-C,hsCRP,TNF-α,IL-6 and LADd in the three groups.Compared with the control group and the low-dose group,the middle-dose group had significant differences in heart function indexes,blood lipids TG,TC,HDL-C indexes,and inflammation in-dexes.With time going by,the heart function indexes and blood lipids indicators(TG,TC,HDL-C)and all indi-cators of inflammation have significant changes.In the three groups of patients,blood TG,TC,HDL-C and in-flammation indexes were significantly decreased with time.The efficacy of the middle-dose group was significantly better than that of the low-dose group and the control group,and the effective rate was higher than that of the low-dose group and the control group.The relapse rate of the middle-dose group was significantly lower than that of the low-dose group and the control group.Conclusion Rosuvastatin can reduce the recurrence rate of atrial fi-brillation in patients with acute myocardial infarction,change the patient's heart function index,blood lipid index and inflammation index effectively.